| Quarter (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| 13F holders | Current |
|---|---|
| Total holders | 15 |
| Opened positions | 4 |
| Closed positions | 1 |
| Increased positions | 1 |
| Reduced positions | 1 |
| 13F shares | Current |
|---|---|
| Total value | 143.41 mm |
| Total shares | 5.37 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Baharaff Allen | 3.42 mm | $0.00 |
| Biotechnology Value Fund L P | 1.74 mm | $0.00 |
| CVI Investments | 167.26 k | $585.00 k |
| Schonfeld Strategic Advisors | 25.40 k | $81.03 mm |
| MS Morgan Stanley | 12.53 k | $39.97 mm |
| UBS UBS | 6.72 k | $21.44 mm |
| Tower Research Capital | 59.00 | $188.00 k |
| WFC Wells Fargo & Company | 18.00 | $57.00 k |
| TSFG | 17.00 | $0.00 |
| SBI Securities | 16.00 | $51.00 k |
